Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Umbricht, Christopher B Johns Hopkins University Discovery and validation of early molecular breast cancer risk markers in benign breast disease PA-16-160: NIH Research Project Grant
Hitchins, Megan P Cedars-Sinai Medical Center Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age PA-20-185: NIH Research Project Grant
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Figueiredo, Jane C. Cedars-Sinai Medical Center Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Turesky, Robert J. University Of Minnesota DNA adductomics of the urinary system PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Zada, Gabriel University Of Southern California DNA Methylation and gene expression variations influence pituitary adenoma hormonal function and invasive growth PA-16-160: NIH Research Project Grant
Grimm, Lars J Duke University Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Papadopoulos, Nickolas Johns Hopkins University Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Wang, Thomas D University Of Michigan At Ann Arbor Early detection of colorectal cancer in the traditional and serrated pathways Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Beretta, Laura University Of Tx Md Anderson Can Ctr Early Detection of Hepatocellular Carcinoma Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Genkinger, Jeanine M. Columbia University Health Sciences Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI PA-13-302: Research Project Grant
Lee, Hakho Massachusetts General Hospital Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Ivanov, Alexander R. Northeastern University Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Wong, David T University Of California Los Angeles EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment

Pages